Cancers of the biliary tract, cholangiocarcinoma and gallbladder cancer, are rare
malignancies in many regions of the world, but is a group of malignancies with a high …

[緒言] 治療の進歩に伴い, 様々な癌腫において生存期間の延長が得られている. 一方,
外科的切除が唯一の根治手段である胆道癌は, 手術手技や周術期管理の改善にも関わらず …

Simple Summary Biliary tract cancers (BTCs) are a heterogeneous group of malignancies,
which arise from the epithelial cells of the biliary tree, with a high rate of local invasion and …

Background We sought to define the association of the systemic immune inflammation index
(SII) with prognosis and adjuvant therapy benefit among patients undergoing resection of …

Background: Biliary tract cancers (BTC) are relatively rare malignant tumours with poor
prognosis. It is known from other solid neoplasms that antitumour inflammatory response …

Background: Systemic inflammation is relevant in intrahepatic cholangiocarcinoma (iCCA),
but controversial results exist on the prognostic role of inflammatory indexes and their …

Introduction Recently, the advanced lung cancer inflammation index (ALI), combining
inflammation and nutrition data, was proposed as a prognostic biomarker. We assessed the …

Cholangiocarcinoma (CCA) is a lethal disease. A new predictive factor to identify patients
suitable for adjuvant chemotherapy is needed. The relationship between the long‑term …

Background/Aim: Inflammation-based prognostic scores are proven prognostic biomarkers
in various cancers. This study aimed to identify a useful prognostic score for patients with …

Background The systemic immune-inflammation index (SII) is a significant prognostic factor
for neoplastic diseases. However, the prognostic value of SII in patients with …